Tom Jaspers

1.2k total citations
13 papers, 313 citations indexed

About

Tom Jaspers is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Tom Jaspers has authored 13 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Neurology. Recurrent topics in Tom Jaspers's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Tom Jaspers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Tom Jaspers collaborates with scholars based in Belgium, United States and United Kingdom. Tom Jaspers's co-authors include Maarten Dewilde, Bart De Strooper, Yessica Wouters, Wim Robberecht, Ludo Van Den Bosch, Philip Van Damme, Vincent Thijs, Robin Lemmens, Elisabeth Rossaert and Lawrence Van Helleputte and has published in prestigious journals such as Nature Neuroscience, Biochemical and Biophysical Research Communications and Human Molecular Genetics.

In The Last Decade

Tom Jaspers

11 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Jaspers Belgium 10 171 85 67 56 52 13 313
Laura Rué Belgium 13 266 1.6× 114 1.3× 193 2.9× 63 1.1× 56 1.1× 21 453
Nuno Jorge Lamas Portugal 10 239 1.4× 77 0.9× 112 1.7× 91 1.6× 45 0.9× 29 442
Lotta E. Oikari Australia 12 171 1.0× 46 0.5× 58 0.9× 100 1.8× 78 1.5× 22 441
Soshana Svendsen United States 7 259 1.5× 78 0.9× 101 1.5× 87 1.6× 49 0.9× 9 470
Wendy Bautista Canada 11 297 1.7× 68 0.8× 104 1.6× 36 0.6× 39 0.8× 18 497
Robert Prior Belgium 7 179 1.0× 79 0.9× 139 2.1× 37 0.7× 40 0.8× 7 296
Grace E. Lidgerwood Australia 14 423 2.5× 67 0.8× 61 0.9× 15 0.3× 54 1.0× 21 552
Izabela Karbassi United States 8 113 0.7× 38 0.4× 119 1.8× 54 1.0× 45 0.9× 11 275
Regina T. Martuscello United States 10 157 0.9× 131 1.5× 121 1.8× 25 0.4× 108 2.1× 14 418
Masashi Takata Japan 7 139 0.8× 57 0.7× 107 1.6× 108 1.9× 24 0.5× 16 401

Countries citing papers authored by Tom Jaspers

Since Specialization
Citations

This map shows the geographic impact of Tom Jaspers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Jaspers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Jaspers more than expected).

Fields of papers citing papers by Tom Jaspers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Jaspers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Jaspers. The network helps show where Tom Jaspers may publish in the future.

Co-authorship network of co-authors of Tom Jaspers

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Jaspers. A scholar is included among the top collaborators of Tom Jaspers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Jaspers. Tom Jaspers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Albertini, Giulia, An Snellinx, Suresh Poovathingal, et al.. (2025). The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia. Nature Neuroscience. 29(1). 100–110.
2.
3.
Jaspers, Tom, Christopher Cawthorne, Guy Bormans, et al.. (2025). Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein. Fluids and Barriers of the CNS. 22(1). 11–11. 4 indexed citations
4.
Rué, Laura, Tom Jaspers, Sam Noppen, et al.. (2023). Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. Pharmaceutics. 15(6). 1748–1748. 14 indexed citations
5.
Prior, Robert, Katlijn Vints, Tom Jaspers, et al.. (2022). HDAC3 Inhibition Stimulates Myelination in a CMT1A Mouse Model. Molecular Neurobiology. 59(6). 3414–3430. 13 indexed citations
6.
Wouters, Yessica, Tom Jaspers, Laura Rué, et al.. (2022). VHHs as tools for therapeutic protein delivery to the central nervous system. Fluids and Barriers of the CNS. 19(1). 79–79. 26 indexed citations
7.
Wouters, Yessica, Tom Jaspers, Dimitri De Bundel, et al.. (2021). Applicability of cerebral open flow microperfusion and microdialysis to quantify a brain-penetrating nanobody in mice. Analytica Chimica Acta. 1178. 338803–338803. 11 indexed citations
8.
Wouters, Yessica, Tom Jaspers, Bart De Strooper, & Maarten Dewilde. (2020). Identification and in vivo characterization of a brain-penetrating nanobody. Fluids and Barriers of the CNS. 17(1). 62–62. 53 indexed citations
9.
Rossaert, Elisabeth, Eveliina Pollari, Tom Jaspers, et al.. (2019). Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathologica Communications. 7(1). 107–107. 66 indexed citations
10.
Helleputte, Lawrence Van, Dana P. Cook, Elisabeth Rossaert, et al.. (2017). Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiology of Disease. 111. 59–69. 54 indexed citations
11.
Lemmens, Robin, Tom Jaspers, Wim Robberecht, & Vincent Thijs. (2013). Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke. Human Molecular Genetics. 22(11). 2214–2220. 46 indexed citations
12.
Staats, Kim A., Lawrence Van Helleputte, Ashley Jones, et al.. (2013). Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice. Neurobiology of Disease. 60. 11–17. 14 indexed citations
13.
Staats, Kim A., Elke Bogaert, Nicole Hersmus, et al.. (2012). Neuronal overexpression of IP3 receptor 2 is detrimental in mutant SOD1 mice. Biochemical and Biophysical Research Communications. 429(3-4). 210–213. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Rué Breakdown of academic impact, for papers by Nuno Jorge Lamas Breakdown of academic impact, for papers by Lotta E. Oikari Breakdown of academic impact, for papers by Soshana Svendsen Breakdown of academic impact, for papers by Wendy Bautista Breakdown of academic impact, for papers by Robert Prior Breakdown of academic impact, for papers by Grace E. Lidgerwood Breakdown of academic impact, for papers by Izabela Karbassi Breakdown of academic impact, for papers by Regina T. Martuscello Breakdown of academic impact, for papers by Masashi Takata
Rankless by CCL
2026